These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. Zhu J; Huang X; Yang Y J Virol; 2007 Apr; 81(7):3170-80. PubMed ID: 17229689 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. Appledorn DM; Patial S; McBride A; Godbehere S; Van Rooijen N; Parameswaran N; Amalfitano A J Immunol; 2008 Aug; 181(3):2134-44. PubMed ID: 18641352 [TBL] [Abstract][Full Text] [Related]
11. Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection. Chen RF; Lee CY Int Rev Immunol; 2014 Jan; 33(1):45-53. PubMed ID: 24127823 [TBL] [Abstract][Full Text] [Related]
12. The innate immune response to adenovirus vectors. Muruve DA Hum Gene Ther; 2004 Dec; 15(12):1157-66. PubMed ID: 15684693 [TBL] [Abstract][Full Text] [Related]
14. Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys. Collignon C; Bol V; Chalon A; Surendran N; Morel S; van den Berg RA; Capone S; Bechtold V; Temmerman ST Front Immunol; 2020; 11():579872. PubMed ID: 33329551 [TBL] [Abstract][Full Text] [Related]
15. Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblasts. Tsitoura E; Thomas J; Cuchet D; Thoinet K; Mavromara P; Epstein AL J Gen Virol; 2009 Sep; 90(Pt 9):2209-20. PubMed ID: 19515829 [TBL] [Abstract][Full Text] [Related]
16. Signaling danger: toll-like receptors and their potential roles in kidney disease. Anders HJ; Banas B; Schlöndorff D J Am Soc Nephrol; 2004 Apr; 15(4):854-67. PubMed ID: 15034087 [TBL] [Abstract][Full Text] [Related]
17. Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule. Rollier CS; Spencer AJ; Sogaard KC; Honeycutt J; Furze J; Bregu M; Gilbert SC; Wyllie D; Hill AVS Sci Rep; 2020 Mar; 10(1):5716. PubMed ID: 32235848 [TBL] [Abstract][Full Text] [Related]
18. Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System. Cerullo V; Capasso C; Vaha-Koskela M; Hemminki O; Hemminki A Curr Cancer Drug Targets; 2018; 18(2):124-138. PubMed ID: 28464762 [TBL] [Abstract][Full Text] [Related]
19. Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus. Ahtiainen L; Mirantes C; Jahkola T; Escutenaire S; Diaconu I; Osterlund P; Kanerva A; Cerullo V; Hemminki A PLoS One; 2010 Nov; 5(11):e13859. PubMed ID: 21079774 [TBL] [Abstract][Full Text] [Related]
20. A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo. Zhu J; Huang X; Yang Y Mol Ther; 2008 Jul; 16(7):1300-7. PubMed ID: 18443600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]